Met Life Investment Management, LLC Blueprint Medicines Corp Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Met Life Investment Management, LLC holds 36,269 shares of BPMC stock, worth $3.28 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

36,269

Previous 36,269 -0.0%

Holding current value

$3.28 Million

Previous $3.91 Million 14.22%

% of portfolio

0.02%

Previous 0.02%

45 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$85.18 - $108.78 $437,399 - $558,585	5,135 Added 16.49%	36,269 $3.91 Million
Q1 2024 May 14, 2024	BUY	$73.17 - $99.79 $2.28 Million - $3.11 Million	31,134 New	31,134 $2.95 Million
Q3 2023 May 09, 2024	BUY	$46.9 - $66.0 $25,044 - $35,244	534 Added 1.68%	32,316 $1.62 Million
Q2 2023 Apr 29, 2024	BUY	$42.2 - $66.37 $1.36 Million - $2.14 Million	32,316 New	32,316 $2.04 Million
Q2 2023 Aug 10, 2023	BUY	$42.2 - $66.37 $22,534 - $35,441	534 Added 1.68%	32,316 $2.04 Million
Q1 2023 May 09, 2024	BUY	$37.97 - $50.0 $1.21 Million - $1.59 Million	31,782 New	31,782 $1.43 Billion
Q1 2022 May 10, 2024	BUY	$54.1 - $110.08 $1.72 Million - $3.5 Million	31,782 New	31,782 $2.03 Million
Q1 2022 Mar 22, 2023	BUY	$54.1 - $110.08 $602,187 - $1.23 Million	11,131 Added 53.9%	31,782 $2.03 Million
Q1 2022 May 12, 2022	BUY	$54.1 - $110.08 $602,187 - $1.23 Million	11,131 Added 53.9%	31,782 $2.03 Million
Q4 2021 Jun 21, 2023	SELL	$94.25 - $115.99 $1.05 Million - $1.29 Million	-11,131 Reduced 35.02%	20,651 $2.21 Million
Q3 2021 Jun 21, 2023	SELL	$80.98 - $109.47 $901,388 - $1.22 Million	-11,131 Reduced 35.02%	20,651 $2.12 Million
Q2 2021 Jun 21, 2023	SELL	$82.78 - $101.0 $921,424 - $1.12 Million	-11,131 Reduced 35.02%	20,651 $1.82 Million
Q1 2021 May 17, 2024	SELL	$90.71 - $108.28 $950,912 - $1.14 Million	-10,483 Reduced 33.67%	20,651 $2.01 Million
Q1 2021 Jun 26, 2023	SELL	$90.71 - $108.28 $1.01 Million - $1.21 Million	-11,131 Reduced 35.02%	20,651 $2.01 Billion
Q1 2021 Mar 22, 2023	SELL	$90.71 - $108.28 $107,309 - $128,095	-1,183 Reduced 5.42%	20,651 $2.01 Million
Q1 2021 May 14, 2021	SELL	$90.71 - $108.28 $107,309 - $128,095	-1,183 Reduced 5.42%	20,651 $2.01 Million
Q4 2020 May 24, 2024	SELL	$92.08 - $124.48 $188,211 - $254,437	-2,044 Reduced 8.56%	21,834 $2.45 Million
Q4 2020 Jun 22, 2023	SELL	$92.08 - $124.48 $916,011 - $1.24 Million	-9,948 Reduced 31.3%	21,834 $2.45 Million
Q4 2020 Mar 22, 2023	SELL	$92.08 - $124.48 $188,211 - $254,437	-2,044 Reduced 8.56%	21,834 $2.45 Million
Q4 2020 Feb 16, 2021	SELL	$92.08 - $124.48 $188,211 - $254,437	-2,044 Reduced 8.56%	21,834 $2.45 Million
Q3 2020 Jun 26, 2023	SELL	$66.45 - $92.7 $525,220 - $732,700	-7,904 Reduced 24.87%	23,878 $2.21 Million
Q2 2020 May 24, 2024	SELL	$57.09 - $79.27 $414,245 - $575,183	-7,256 Reduced 23.31%	23,878 $1.86 Billion
Q2 2020 Jun 26, 2023	SELL	$57.09 - $79.27 $451,239 - $626,550	-7,904 Reduced 24.87%	23,878 $1.86 Million
Q2 2020 Mar 22, 2023	BUY	$57.09 - $79.27 $78,384 - $108,837	1,373 Added 6.1%	23,878 $1.86 Million
Q2 2020 Aug 14, 2020	BUY	$57.09 - $79.27 $78,384 - $108,837	1,373 Added 6.1%	23,878 $1.86 Million
Q1 2020 Jul 12, 2023	SELL	$48.11 - $82.22 $446,316 - $762,754	-9,277 Reduced 29.19%	22,505 $1.32 Million
Q1 2020 Mar 22, 2023	BUY	$48.11 - $82.22 $95,690 - $163,535	1,989 Added 9.69%	22,505 $1.32 Million
Q1 2020 May 15, 2020	BUY	$48.11 - $82.22 $95,690 - $163,535	1,989 Added 9.69%	22,505 $1.32 Million
Q4 2019 Jul 12, 2023	SELL	$66.73 - $82.59 $751,780 - $930,458	-11,266 Reduced 35.45%	20,516 $1.64 Million
Q4 2019 Mar 22, 2023	SELL	$66.73 - $82.59 $83,746 - $103,650	-1,255 Reduced 5.76%	20,516 $1.64 Million
Q4 2019 Feb 14, 2020	SELL	$66.73 - $82.59 $83,746 - $103,650	-1,255 Reduced 5.76%	20,516 $1.64 Million
Q3 2019 Jul 12, 2023	SELL	$72.9 - $101.41 $729,801 - $1.02 Million	-10,011 Reduced 31.5%	21,771 $1.6 Million
Q3 2019 Mar 22, 2023	BUY	$72.9 - $101.41 $169,273 - $235,474	2,322 Added 11.94%	21,771 $1.6 Million
Q3 2019 Nov 14, 2019	BUY	$72.9 - $101.41 $169,273 - $235,474	2,322 Added 11.94%	21,771 $1.6 Million
Q2 2019 Jul 12, 2023	SELL	$73.54 - $97.8 $736,208 - $979,075	-10,011 Reduced 31.5%	21,771 $2.05 Million
Q2 2019 Mar 22, 2023	BUY	$73.54 - $97.8 $120,826 - $160,685	1,643 Added 9.23%	19,449 $1.83 Million
Q2 2019 Aug 14, 2019	BUY	$73.54 - $97.8 $120,826 - $160,685	1,643 Added 9.23%	19,449 $1.84 Million
Q1 2019 Jul 13, 2023	SELL	$48.7 - $86.6 $680,631 - $1.21 Million	-13,976 Reduced 43.97%	17,806 $1.43 Million
Q4 2018 Jul 13, 2023	SELL	$45.57 - $74.26 $636,886 - $1.04 Million	-13,976 Reduced 43.97%	17,806 $959,000
Q4 2018 Mar 22, 2023	SELL	$45.57 - $74.26 $478,986 - $780,546	-10,511 Reduced 37.12%	17,806 $959,000
Q4 2018 Feb 14, 2019	SELL	$45.57 - $74.26 $478,986 - $780,546	-10,511 Reduced 37.12%	17,806 $960,000
Q3 2018 Jul 13, 2023	SELL	$58.91 - $78.32 $823,326 - $1.09 Million	-13,976 Reduced 43.97%	17,806 $1.39 Million
Q3 2018 Mar 22, 2023	SELL	$58.91 - $78.32 $204,123 - $271,378	-3,465 Reduced 10.9%	28,317 $2.21 Million
Q3 2018 Nov 14, 2018	BUY	$58.91 - $78.32 $527,185 - $700,885	8,949 Added 46.21%	28,317 $2.21 Million
Q4 2017 Feb 15, 2018	BUY	$62.91 - $88.32 $1.22 Million - $1.71 Million	19,368	19,368 $1.46 Million

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Blueprint Medicines Corp Transaction History